GLP-1 medications like semaglutide (Wegovy, Ozempic) or the dual agonist tirzepatide (Zepbound, Mounjaro) reduce appetite and slow gastric emptying, making it easier to eat less without constant hunger
In vitro prophylactic injection of IL-22 can significantly reduce the expression of pro-inflammatory factors IL-6, IL-1, TNF-, and the liver necrosis area and increase the expression of hepatocyte proliferation marker Ki-67, suggesting that IL-22 through promoting hepatocyte proliferation mediates hepatoprotective functions and has the therapeutic potential in AILI [174]
[15] The therapy is used off-label based on emerging science and clinical experience
Administration: Lipo-C is administered via intramuscular injection (IM), typically in either the upper arm (deltoid) or the buttocks (gluteus)
Avoid it with eczema or broken skin since mometasone thins inflamed areas
In terms of general use for treating obesity or overweight conditions with accompanying health risks, evidence suggests that Wegovy performs similarly to placebo plus lifestyle intervention for achieving clinically meaningful weight loss after one year
